PP2A-β Activators comprise a select group of chemical compounds that indirectly augment the functional activity of PP2A-β through various intracellular mechanisms, primarily by inhibiting the activity of competing phosphatases. Fostriecin, Cantharidin, Okadaic Acid, Calyculin A, Endothall, Microcystin-LR, Tautomycin, Norcantharidin, Phenothiazines, Rubratoxin B, and LB-100 all function by selectively inhibiting serine/threonine phosphatases that compete with PP2A-β, ensuring that PP2A-β retains a larger pool of substrates for its dephosphorylation actions, thus indirectly enhancing its activity. These inhibitors, while themselves not acting directly on PP2A-β, create a biochemical environment that favors PP2A-β's activity through the reduction of its competitors' influence, effectively shifting the cellular equilibrium towards the pathways PP2A-β regulates such as cell cycle control, apoptosis, and DNA damage repair.
Additionally, some compounds like Ionomycin exert their effects by modulating intracellular calcium levels, which can promote PP2A-β activity through calcium-dependent signaling mechanisms. The alteration of calcium homeostasis by Ionomycin may lead to the activation of calcium-sensitive enzymes and proteins that work in concert with PP2A-β, enhancing its role in cellular signaling pathways. Collectively, these PP2A-β Activators, through their targeted biochemical actions, facilitate the enhancement of PP2PP2A-β Activators encompass a range of chemical compounds that indirectly enhance the functional activity of PP2A-β by influencing the cellular environment and signaling pathways to favor its activity. The strategy behind activating PP2A-β involves the selective inhibition of its competitive phosphatases, thereby indirectly amplifying its role in dephosphorylation processes. Compounds such as Fostriecin, Cantharidin, and Okadaic Acid specifically target PP2A-β's competitors like PP1, diminishing their activity and consequently allowing PP2A-β to operate on a broader spectrum of substrates. This selective inhibition is also seen with Calyculin A, Endothall, and Microcystin-LR, which, by binding to and inhibiting other serine/threonine phosphatases, ensure that PP2A-β's phosphatase activity is relatively upregulated. Norcantharidin, a demethylated analog of cantharidin, and chemical classes like Phenothiazines further contribute to this effect by their preferential inhibition of other phosphatases, indirectly increasing the functional capacity of PP2A-β in cellular processes such as cell cycle regulation and signal transduction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is phosphorylated in vivo to form FTY720-P, which acts as a sphingosine-1-phosphate receptor modulator. This leads to the activation of the PP2A-β by promoting its re-association with regulatory subunits, thereby enhancing its phosphatase activity. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
Ceramide, a sphingolipid, acts on intracellular signaling pathways and can activate PP2A-β by altering the composition of its regulatory subunits, which can change the substrate specificity and localization, resulting in increased phosphatase activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in cAMP levels, which indirectly enhances PP2A-β activity by promoting the dissociation of its inhibitory subunits through PKA-mediated phosphorylation events. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits PP2A-β's close relative PP1, which can result in a compensatory enhancement of PP2A-β activity to maintain overall phosphatase activity within the cell. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
D-erythro-Sphingosine functions similarly to ceramide, as it is involved in sphingolipid signaling that can modulate PP2A-β's conformation and enhance its activity by influencing the composition of its subunits. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Endothall is a PP2A-β inhibitor, but at low concentrations, it may paradoxically enhance PP2A-β activity by stabilizing the enzyme in a conformation that favors the binding of its physiological substrates. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a well-known inhibitor of PP2A, but it can enhance PP2A-β activity at sub-inhibitory concentrations by inducing a mild stress response that results in a compensatory upregulation of PP2A-β's activity. | ||||||
Phytosphingosine | 554-62-1 | sc-201385 sc-201385A | 5 mg 25 mg | $102.00 $427.00 | 4 | |
Sphingosylphosphorylcholine alters the lipid environment of PP2A-β, which can modulate its activity by changing the interaction with its regulatory subunits, thereby enhancing the phosphatase activity. | ||||||
Sodium selenate | 13410-01-0 | sc-251052A sc-251052 sc-251052B sc-251052C | 25 g 100 g 500 g 1 kg | $52.00 $187.00 $332.00 $599.00 | ||
Sodium Selenate is known to activate PP2A-β by promoting the dephosphorylation of its C subunit, which is essential for the catalytic activity of PP2A-β. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic trioxide has been shown to enhance PP2A-β activity by promoting the formation of PP2A-β-containing trimeric complexes, which are more active than the dimeric or monomeric forms. | ||||||